Lochhead Pamela A, Kinstrie Ross, Sibbet Gary, Rawjee Teeara, Morrice Nick, Cleghon Vaughn
The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow, G61 1BD.
Mol Cell. 2006 Nov 17;24(4):627-33. doi: 10.1016/j.molcel.2006.10.009.
Glycogen synthase kinase 3 (GSK3), a key component of the insulin and wnt signaling pathways, is unusual, as it is constitutively active and is inhibited in response to upstream signals. Kinase activity is thought to be increased by intramolecular phosphorylation of a tyrosine in the activation loop (Y216 in GSK3beta), whose timing and mechanism is undefined. We show that GSK3beta autophosphorylates Y216 as a chaperone-dependent transitional intermediate possessing intramolecular tyrosine kinase activity and displaying different sensitivity to small-molecule inhibitors compared to mature GSK3beta. After autophosphorylation, mature GSK3beta is then an intermolecular serine/threonine kinase no longer requiring a chaperone. This shows that autoactivating kinases have adopted different molecular mechanisms for autophosphorylation; and for kinases such as GSK3, inhibitors that affect only the transitional intermediate would be missed in conventional drug screens.
糖原合酶激酶3(GSK3)是胰岛素和Wnt信号通路的关键组成部分,它不同寻常,因为它是组成型激活的,并且会响应上游信号而被抑制。激酶活性被认为是由激活环中酪氨酸的分子内磷酸化(GSK3β中的Y216)增加的,其时间和机制尚不清楚。我们发现,GSK3β将Y216自磷酸化,形成一种依赖伴侣蛋白的过渡中间体,该中间体具有分子内酪氨酸激酶活性,并且与成熟的GSK3β相比,对小分子抑制剂表现出不同的敏感性。自磷酸化后,成熟的GSK3β成为一种分子间丝氨酸/苏氨酸激酶,不再需要伴侣蛋白。这表明自激活激酶采用了不同的自磷酸化分子机制;对于像GSK3这样的激酶,在传统药物筛选中会遗漏仅影响过渡中间体的抑制剂。